Experimental basis of cord blood transplantation

Hal Broxmeyer, S. Cooper, D. M. Hass, J. K. Hathaway, Frederick Stehman, G. Hangoc

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Efforts are needed to enhance the efficacy of cord blood (CB) transplantation. Laboratory information set the stage for the first and subsequent CB transplants, and will be instrumental in continuing to advance the field. This paper offers a brief understanding of the current state of hematopoietic stem cell (HSC) and hematopoietic progenitor cell (HPC) biology, a look back at laboratory studies leading to the first CB transplants, and a discussion of the possible means to enhance CB transplantation. Results show that physical recovery of greater numbers of HPCs is possible after CB is collected by perfusing the placenta, but how realistic this procedure is for collection of CB to be banked is open to question. We also show that the chemokine stromal cell-derived factor-1/CXCL12 can enhance the ex vivo expansion of CB HPCs beyond that of the combination of SCF, Flt3-ligand and TPO. Advances in cytokine and stromal cell biology, and in intracellular signals mediating the effects of cytokines/stromal cells should be considered in the context of future efforts to enhance functional activities of donor CB HSCs and HPCs and the microenvironmental niche of the recipient, which is required for acceptance and nurturing these HSCs/HPCs.

Original languageEnglish
Pages (from-to)627-633
Number of pages7
JournalBone Marrow Transplantation
Volume44
Issue number10
DOIs
StatePublished - Nov 2009

Fingerprint

Fetal Blood
Transplantation
Stromal Cells
Hematopoietic Stem Cells
Cell Biology
Cytokines
Transplants
Chemokine CXCL12
Chemokines
Placenta

Keywords

  • Cord blood
  • Cytokines
  • Hematopoietic progenitor cells
  • Hematopoietic stem cells
  • Transplantation

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Experimental basis of cord blood transplantation. / Broxmeyer, Hal; Cooper, S.; Hass, D. M.; Hathaway, J. K.; Stehman, Frederick; Hangoc, G.

In: Bone Marrow Transplantation, Vol. 44, No. 10, 11.2009, p. 627-633.

Research output: Contribution to journalArticle

Broxmeyer, H, Cooper, S, Hass, DM, Hathaway, JK, Stehman, F & Hangoc, G 2009, 'Experimental basis of cord blood transplantation', Bone Marrow Transplantation, vol. 44, no. 10, pp. 627-633. https://doi.org/10.1038/bmt.2009.285
Broxmeyer, Hal ; Cooper, S. ; Hass, D. M. ; Hathaway, J. K. ; Stehman, Frederick ; Hangoc, G. / Experimental basis of cord blood transplantation. In: Bone Marrow Transplantation. 2009 ; Vol. 44, No. 10. pp. 627-633.
@article{5b7612825260479b983aca404ee3cc3e,
title = "Experimental basis of cord blood transplantation",
abstract = "Efforts are needed to enhance the efficacy of cord blood (CB) transplantation. Laboratory information set the stage for the first and subsequent CB transplants, and will be instrumental in continuing to advance the field. This paper offers a brief understanding of the current state of hematopoietic stem cell (HSC) and hematopoietic progenitor cell (HPC) biology, a look back at laboratory studies leading to the first CB transplants, and a discussion of the possible means to enhance CB transplantation. Results show that physical recovery of greater numbers of HPCs is possible after CB is collected by perfusing the placenta, but how realistic this procedure is for collection of CB to be banked is open to question. We also show that the chemokine stromal cell-derived factor-1/CXCL12 can enhance the ex vivo expansion of CB HPCs beyond that of the combination of SCF, Flt3-ligand and TPO. Advances in cytokine and stromal cell biology, and in intracellular signals mediating the effects of cytokines/stromal cells should be considered in the context of future efforts to enhance functional activities of donor CB HSCs and HPCs and the microenvironmental niche of the recipient, which is required for acceptance and nurturing these HSCs/HPCs.",
keywords = "Cord blood, Cytokines, Hematopoietic progenitor cells, Hematopoietic stem cells, Transplantation",
author = "Hal Broxmeyer and S. Cooper and Hass, {D. M.} and Hathaway, {J. K.} and Frederick Stehman and G. Hangoc",
year = "2009",
month = "11",
doi = "10.1038/bmt.2009.285",
language = "English",
volume = "44",
pages = "627--633",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Experimental basis of cord blood transplantation

AU - Broxmeyer, Hal

AU - Cooper, S.

AU - Hass, D. M.

AU - Hathaway, J. K.

AU - Stehman, Frederick

AU - Hangoc, G.

PY - 2009/11

Y1 - 2009/11

N2 - Efforts are needed to enhance the efficacy of cord blood (CB) transplantation. Laboratory information set the stage for the first and subsequent CB transplants, and will be instrumental in continuing to advance the field. This paper offers a brief understanding of the current state of hematopoietic stem cell (HSC) and hematopoietic progenitor cell (HPC) biology, a look back at laboratory studies leading to the first CB transplants, and a discussion of the possible means to enhance CB transplantation. Results show that physical recovery of greater numbers of HPCs is possible after CB is collected by perfusing the placenta, but how realistic this procedure is for collection of CB to be banked is open to question. We also show that the chemokine stromal cell-derived factor-1/CXCL12 can enhance the ex vivo expansion of CB HPCs beyond that of the combination of SCF, Flt3-ligand and TPO. Advances in cytokine and stromal cell biology, and in intracellular signals mediating the effects of cytokines/stromal cells should be considered in the context of future efforts to enhance functional activities of donor CB HSCs and HPCs and the microenvironmental niche of the recipient, which is required for acceptance and nurturing these HSCs/HPCs.

AB - Efforts are needed to enhance the efficacy of cord blood (CB) transplantation. Laboratory information set the stage for the first and subsequent CB transplants, and will be instrumental in continuing to advance the field. This paper offers a brief understanding of the current state of hematopoietic stem cell (HSC) and hematopoietic progenitor cell (HPC) biology, a look back at laboratory studies leading to the first CB transplants, and a discussion of the possible means to enhance CB transplantation. Results show that physical recovery of greater numbers of HPCs is possible after CB is collected by perfusing the placenta, but how realistic this procedure is for collection of CB to be banked is open to question. We also show that the chemokine stromal cell-derived factor-1/CXCL12 can enhance the ex vivo expansion of CB HPCs beyond that of the combination of SCF, Flt3-ligand and TPO. Advances in cytokine and stromal cell biology, and in intracellular signals mediating the effects of cytokines/stromal cells should be considered in the context of future efforts to enhance functional activities of donor CB HSCs and HPCs and the microenvironmental niche of the recipient, which is required for acceptance and nurturing these HSCs/HPCs.

KW - Cord blood

KW - Cytokines

KW - Hematopoietic progenitor cells

KW - Hematopoietic stem cells

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=75149195760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75149195760&partnerID=8YFLogxK

U2 - 10.1038/bmt.2009.285

DO - 10.1038/bmt.2009.285

M3 - Article

VL - 44

SP - 627

EP - 633

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 10

ER -